Day One Biopharmaceuticals, Inc. (DAWN) — Analyst estimates
Consensus analyst estimates for Day One Biopharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 67.29M | -0.16 | 1 |
| 2027 | 87.20M | -0.14 | 1 |
| 2028 | 398.7M | 0.25 | 5 |
| 2029 | 532.92M | 1.25 | 1 |
| 2030 | 637.33M | 1.85 | 1 |
Consensus analyst estimates by fiscal year.